Kenneth Hallock

Kenneth Hallock is a declared insider of Greenwich LifeSciences, Inc. (board member), with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 29 September 2020 and the latest from 21 January 2022.

On the market, this insider has only ever bought: 5 purchases, €412k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises. So far in 2022, the count stands at 1 purchase and no sales.

The median purchase comes to €4,548. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 24 January 2022: an open-market purchase of €4,327, in Greenwich LifeSciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.